Sandrine Niyongere

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Drug Administration

Acute Lymphoblastic Leukemia

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation. Cancer research communications (2024)
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation. Cancer research communications 4 (2) (2024)
Jonelle K Lee, Aditi Chatterjee, Mario Scarpa, Christopher M Bailey, Sandrine Niyongere, Prerna Singh, Moaath K Mustafa Ali, Shivani Kapoor, Yin Wang, Giovannino Silvestri, Maria R Baer
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation. Cancer research communications 4 (2) (2024)
Sarah M Kashanian, Noa G Holtzman, Ciera L Patzke, Jonathan Cornu, Alison P Duffy, Madhurima Koka, Sandrine Niyongere, Vu H Duong, Maria R Baer, Jummai Apata, Farin Kamangar, Ashkan Emadi
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer chemotherapy and pharmacology 87 (6) (2021)